Trials / Completed
CompletedNCT00504712
Testosterone for Peripheral Vascular Disease
A Randomised, Double Blind, Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Barnsley Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
There is increasing evidence of the linkage of type 2 diabetes with low testosterone levels in men.
Detailed description
Testosterone treatment has shown beneficial effects on blood sugar control and obesity in pilot studies in men with type 2 diabetes. Beneficial effects have also been seen on angina- a disease related to atherosclerosis (narrowing of the arterial blood vessels). Peripheral vascular disease is also caused by atherosclerosis. We hypothesise that testosterone will have beneficial effects on peripheral vascualr disease in men with low serum testosterone and type 2 diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone | Sustanon- 200mg- Intramuscular testosterone every 2 weeks |
| DRUG | saline | Saline injection every two weeks |
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2007-07-20
- Last updated
- 2022-06-08
- Results posted
- 2022-05-18
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00504712. Inclusion in this directory is not an endorsement.